Image Credit:Ann Mil Health Sci Res
Outline
Determination of Maximum Transmission Time of the Labeled Complex to Malignant Lymphatic Cells Using Cell Culture
Authors
Abstract
Background: Nowadays, radiotherapy is considered as one of the main methods in cancer treatment, which uses radiation to destroy cancer cells while causing minimal damage to normal tissue and. Another cancer treatment method is photoelectron therapy, which is a new treatment for mass tumors. In this method, high atomic number drugs should be absorbed by tumor cells) while using carriers) so, their atomic number is increased compare to normal cells, which causes more damage to tumor cells when radiation is applied. Thus, applying accurate and effective photoelectron therapy would be possible. The purpose of this study was to identify and analyze the factors affecting uptake of Metrezoate labeled with gallium by lymphatic tumors in cell cultures.. Materials and Methods: Since uptake of Gallium by Malignant lymphatic cells has been reported in numerous researches, Gallium was bonded with a contrast media (metrezoate). Malignant lymphatic cells (Large Cell Lymphoma, Small cell Lymphoma and Bourkit Lymphoma) in specific colonies were grown in gel culture media. Metrezoate-gallium complex was added to the culture media in concentration of 50%, 60% and 75%. Then, absorbed volume was determined by the SPECT imaging system in 72 hrs post-addition of metrezoate-gallium complex and the cells count and the colonies area were measured. Results: Obtained results in 72 hrs revealed that maximum absorption; count quantity and colonies area occurred 4 hrs post-addition of gallium-metrezoate complex solution. Conclusions: As results show, Gallium-metrezoate complex is significantly accumulated in malignant lymphatic cells. As effective atomic number of malignant lymphatic cells is enhanced, it is expected applying photoelectron therapy in this time leads to more effective treatment.
Highlights
References
- 1.References are available in pdf.
Copyright
© 2013, Annals of Military and Health Sciences Research. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.
Similar Articles
Studying a specific tumor marker by a new method and analyzing its efficiency in labeling animals
Navabpour M, Jamshidinia Z, Bakhshandeh M. Studying a specific tumor marker by a new method and analyzing its efficiency in labeling animals. Ann Mil Health Sci Res. 2015;13(1):e62660. doi:
Development of Ga-67 Maltolate Complex as an Imaging Agent
Fazaeli Y, Jalilian AR, Mohammadpour Amini M, Majdabadi A, Rahiminejad A, et al. Development of Ga-67 Maltolate Complex as an Imaging Agent. Iran J Pharm Res. 2012;11(3):e125826. doi: https://doi.org/10.22037/ijpr.2012.1114
Evaluation of a 99mTc-tricine Vascular Disrupting Agent as an In-vivo Imaging in 4T1 Mouse Breast Tumor Model
Erfani M, Shirmardi SP, Shafiei M. Evaluation of a 99mTc-tricine Vascular Disrupting Agent as an In-vivo Imaging in 4T1 Mouse Breast Tumor Model. Iran J Pharm Res. 2017;16(3):e124960. doi: https://doi.org/10.22037/ijpr.2017.2094
Evaluation of cellular S-value of auger electrons emitting 111In radionuclide by Geant4 and its comparison with MCNP5 Monte Carlo codes and MIRD published data
Tajikmansoury MA, Taleshi Ahangari H, Rajabi H, Jadidi M. Evaluation of cellular S-value of auger electrons emitting 111In radionuclide by Geant4 and its comparison with MCNP5 Monte Carlo codes and MIRD published data. koomesh. 2019;21(3):e153117. doi:
Preparation and Biodistribution Studies of a Radiogallium-Acetylacetonate Bis (Thiosemicarbazone) Complex in Tumor-Bearing Rodents
Jalilian AR, Yousefnia H, Shafaii K, Novinrouz A, Rajamand AA. Preparation and Biodistribution Studies of a Radiogallium-Acetylacetonate Bis (Thiosemicarbazone) Complex in Tumor-Bearing Rodents. Iran J Pharm Res. 2012;11(2):e125870. doi: https://doi.org/10.22037/ijpr.2012.1090
More by these authors
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 0
Last Update: 1 week ago
- Scopus by Title (Ref): 0
Last Update: 1 week ago
- CrossRef: 0
Last Update: 6 hours ago
- OpenAlex: 0
Last Update: 10 hours ago
- OpenCitations: 0
Last Update: 5 days ago